DE2661002A1 - - Google Patents

Info

Publication number
DE2661002A1
DE2661002A1 DE19762661002 DE2661002A DE2661002A1 DE 2661002 A1 DE2661002 A1 DE 2661002A1 DE 19762661002 DE19762661002 DE 19762661002 DE 2661002 A DE2661002 A DE 2661002A DE 2661002 A1 DE2661002 A1 DE 2661002A1
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19762661002
Other languages
German (de)
Other versions
DE2661002C2 (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DE2661002A1 publication Critical patent/DE2661002A1/de
Application granted granted Critical
Publication of DE2661002C2 publication Critical patent/DE2661002C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Fertilizers (AREA)
DE2661002A 1975-07-24 1976-07-23 Expired DE2661002C2 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59896675A 1975-07-24 1975-07-24
US05/652,000 US4027019A (en) 1975-07-24 1976-01-23 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method

Publications (2)

Publication Number Publication Date
DE2661002A1 true DE2661002A1 (enExample) 1985-05-02
DE2661002C2 DE2661002C2 (enExample) 1988-03-17

Family

ID=27083202

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2661002A Expired DE2661002C2 (enExample) 1975-07-24 1976-07-23
DE2633210A Expired DE2633210C2 (de) 1975-07-24 1976-07-23 Verwendung von D-17β-Acetoxy-13β-äthyl-17α-äthinyl-gon-4-en-3-on-oxim zur Hemmung der Fertilität und Ovulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2633210A Expired DE2633210C2 (de) 1975-07-24 1976-07-23 Verwendung von D-17β-Acetoxy-13β-äthyl-17α-äthinyl-gon-4-en-3-on-oxim zur Hemmung der Fertilität und Ovulation

Country Status (22)

Country Link
US (1) US4027019A (enExample)
JP (1) JPS5214760A (enExample)
AT (1) AT350748B (enExample)
AU (1) AU501808B2 (enExample)
CA (1) CA1072948A (enExample)
CH (1) CH599249A5 (enExample)
DE (2) DE2661002C2 (enExample)
DK (1) DK145610C (enExample)
ES (1) ES450108A1 (enExample)
FI (1) FI55036C (enExample)
FR (1) FR2318645A1 (enExample)
GB (1) GB1557197A (enExample)
IE (1) IE43581B1 (enExample)
IL (1) IL50103A (enExample)
MX (1) MX3417E (enExample)
NL (1) NL192206C (enExample)
NO (1) NO143350C (enExample)
NZ (1) NZ181130A (enExample)
PH (1) PH12003A (enExample)
PT (1) PT65402B (enExample)
SE (2) SE421800B (enExample)
YU (1) YU39968B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507290A (en) * 1981-04-07 1985-03-26 World Health Organization Esters of 17 α-ethynyl 19-nor-testosterone and 17 α-ethynyl-18-homo-19-nor-testosterone and pharmaceutical compositions containing the same
GB8313921D0 (en) * 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
WO1993013122A1 (de) * 1991-12-22 1993-07-08 Schering Aktiengesellschaft 3-methylsulfonylhydrazono- und 3-oxyimino-steroide, ein verfahren zu deren herstellung, diese steroide enthaltende pharmazeutische präparate sowie ihre verwendung zur herstellung von arzneimitteln
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
JP2004522754A (ja) * 2001-02-02 2004-07-29 ファルマシア・コーポレーション 月経困難症の治療および予防のための組み合わせ治療としてシクロオキシゲナーゼ‐２阻害剤および性ステロイドを使用する方法
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
WO2004091535A2 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
AR039733A1 (es) * 2003-06-25 2005-03-09 Gador Sa Proceso para la obtencion de norelgestromin en distintas relaciones de los isomeros e y z
HUP0301982A2 (hu) * 2003-06-30 2005-04-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás nagy tisztaságú d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-oxim előállítására
US7816546B2 (en) * 2003-06-30 2010-10-19 Richter Gedeon Vegyeszeti Gyar Rt. Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
HUP0301981A2 (hu) * 2003-06-30 2005-04-28 Richter Gedeon Vegyészeti Gyár Rt. Tiszta d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-3E- és 3Z-oxim izomerek, valamint eljárás az izomer keverékek és a tiszta izomerek előállítására
AU2005272647A1 (en) * 2004-08-12 2006-02-23 Sicor, Inc. Process for the preparation of 3-oximino steroids
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780073A (en) * 1966-07-06 1973-12-18 Ortho Pharma Corp 3-oximes of 19-nortestosterone esters
DE1493161C3 (enExample) * 1951-01-28 1974-05-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532689A (en) * 1967-04-20 1970-10-06 Ortho Pharma Corp 3-oxime and 3-oxime esters of 19-nortestosterone
NL7306609A (enExample) * 1972-05-26 1973-11-28
US3912768A (en) * 1972-09-26 1975-10-14 Warner Lambert Co Norethindrone O-alkyloximes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1493161C3 (enExample) * 1951-01-28 1974-05-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen
US3780073A (en) * 1966-07-06 1973-12-18 Ortho Pharma Corp 3-oximes of 19-nortestosterone esters

Also Published As

Publication number Publication date
NO143350C (no) 1981-01-28
NL192206B (nl) 1996-11-01
DK335876A (da) 1977-01-25
AU1535776A (en) 1978-01-05
AT350748B (de) 1979-06-11
ATA543976A (de) 1978-11-15
YU39968B (en) 1985-06-30
DE2633210C2 (de) 1987-04-09
FR2318645A1 (fr) 1977-02-18
FI762116A7 (enExample) 1977-01-25
NO762583L (enExample) 1977-01-25
JPS624400B2 (enExample) 1987-01-30
NO143350B (no) 1980-10-13
IE43581L (en) 1977-01-24
AU501808B2 (en) 1979-06-28
SE7608407L (sv) 1977-01-25
FI55036C (fi) 1979-05-10
NZ181130A (en) 1984-07-06
MX3417E (es) 1980-11-13
NL192206C (nl) 1997-03-04
FI55036B (fi) 1979-01-31
GB1557197A (en) 1979-12-05
PT65402A (en) 1976-08-01
DE2633210A1 (de) 1977-02-17
NL7608210A (nl) 1977-01-26
FR2318645B1 (enExample) 1978-11-17
DK145610B (da) 1982-12-27
IL50103A0 (en) 1976-09-30
SE445458B (sv) 1986-06-23
CH599249A5 (enExample) 1978-05-31
DE2661002C2 (enExample) 1988-03-17
US4027019A (en) 1977-05-31
DK145610C (da) 1983-08-01
IE43581B1 (en) 1981-04-08
YU173376A (en) 1982-08-31
JPS5214760A (en) 1977-02-03
SE7910336L (sv) 1979-12-14
PT65402B (en) 1979-06-09
CA1072948A (en) 1980-03-04
IL50103A (en) 1979-11-30
PH12003A (en) 1978-10-06
SE421800B (sv) 1982-02-01
ES450108A1 (es) 1977-11-16

Similar Documents

Publication Publication Date Title
FI762116A7 (enExample)
CH595670A5 (enExample)
CH597043A5 (enExample)
BG21568A1 (enExample)
BG21726A1 (enExample)
BG21905A1 (enExample)
BG22170A1 (enExample)
CH595923A5 (enExample)
BG22340A1 (enExample)
BG22646A1 (enExample)
BG22704A2 (enExample)
BG22733A1 (enExample)
BG22927A1 (enExample)
BG23040A1 (enExample)
BG23058A1 (enExample)
CH1212475A4 (enExample)
CH1669775A4 (enExample)
CH581171A5 (enExample)
CH585437A5 (enExample)
CH586682A5 (enExample)
CH588663A5 (enExample)
CH588724A (enExample)
CH589447A5 (enExample)
CH590769A5 (enExample)
CH590782A5 (enExample)

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 2633210

8110 Request for examination paragraph 44
AC Divided out of

Ref country code: DE

Ref document number: 2633210

Format of ref document f/p: P

AC Divided out of

Ref country code: DE

Ref document number: 2633210

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8328 Change in the person/name/address of the agent

Free format text: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 81679 MUENCHEN VOSSIUS, C. VOSSIUS, T., RECHTSANWAELTE, 8000 MUENCHEN